Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory, Open-Label, Single Center Study of CXCR4-targeted PET/CT Imaging for Evaluation of Hematological Malignancies

NCT05255926 is registered in ClinicalTrials.gov with Zhongnan Hospital as lead sponsor.

NCT NCT05255926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05255926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory, Open-Label, Single Center Study of CXCR4-targeted PET/CT Imaging for Evaluation of Hematological Malignancies
Lead sponsor
Zhongnan Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
March 1, 2022
Completion date
December 31, 2026
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cxcr4, hematological malignancy, pet/ct